Elsevier,
The Lancet, Volume 397, 8 May 2021
This Article supports SDGs 3 and 10 by showing that some minority ethnic populations in England have excess risks of testing positive for SARS-CoV-2 and of adverse COVID-19 outcomes compared with the White population, even after accounting for differences in sociodemographic, clinical, and household characteristics.
Thanks to fast learning and sustained growth, solar photovoltaics (PV) is today a highly cost-competitive technology, ready to contribute substantially to CO2 emissions mitigation. However, many scenarios assessing global decarbonization pathways, either based on integrated assessment models or partial-equilibrium models, fail to identify the key role that this technology could play, including far lower future PV capacity than that projected by the PV community.
Elsevier, Developments in the Built Environment, Volume 6, May 2021
Urban regions in sub-Saharan Africa are growing significantly more rapid than their also growing rural counterparts. However, the employment perspectives in rural areas are decreasing, and thus the urban growth can become a driver for enhanced livelihoods in the rural areas.
Elsevier, The Lancet Public Health, Volume 6, May 2021
Background: Community-based active case-finding interventions might identify and treat more people with tuberculosis disease than standard case detection. We aimed to assess whether active case-finding interventions can affect tuberculosis epidemiology in the wider community.
Elsevier, Public Health, Volume 194, May 2021
Objectives: In the face of the SARS-CoV-2 pandemic, people with dementia and their carers are contending with serious challenges to their health and wellbeing, due to risk of severe illness, limiting of social contact and disruption to usual activities. Many forms of support for people with dementia and their carers, including singing groups, have moved online using videoconferencing. Previous research has demonstrated the benefits of group singing, which include cognitive stimulation, meaningful activity and peer support.
Alzheimer's Disease (AD) is a devastating neurodegenerative disorder of the brain, clinically characterised by cognitive deficits that gradually worsen over time. There is, at present, no established cure, or disease-modifying treatments for AD. As life expectancy increases globally, the number of individuals suffering from the disease is projected to increase substantially. Cumulative evidence indicates that AD neuropathological process is initiated several years, if not decades, before clinical signs are evident in patients, and diagnosis made.
Elsevier, EBioMedicine, Volume 67, May 2021
Background: The pathological changes in Alzheimer's Disease (AD) and other neurodegenerative disorders begin decades prior to their clinical expression. However, the clinical diagnosis of neurodegenerative dementias is not straightforward. Lactoferrin is an iron-binding, antimicrobial glycoprotein with a plethora of functions, including acting as an important immune modulator and by having a bacteriocidic effect. Two previous studies indicated that salivary lactoferrin could differentiate between neurodegenerative dementias.
